{
  "query": "analysis sensitivity adverse serious",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT06323681",
          "briefTitle": "Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Hepatitis b"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2016,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06330480",
          "briefTitle": "Check@Home: General Population Screening for Early Detection of Atrial Fibrillation and Chronic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-11-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Atrial Fibrillation", "Chronic Kidney Diseases", "Diabetes Mellitus, Type 2"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 320000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01037413",
          "briefTitle": "Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-12-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2010-04-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Scar Prevention"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07284069",
          "briefTitle": "Senicapoc and Perampanel for Newly Diagnosed Glioblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-02-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-11-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Glioblastoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00197145",
          "briefTitle": "Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-07-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2007-09-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infection, Human Immunodeficiency Virus I"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07074639",
          "briefTitle": "Cognitive-Motor Exergame Training in Frail Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-05-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Aging", "Frailty"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 344,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03963401",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-01-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Psoriatic Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 219,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02889809",
          "briefTitle": "Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 477,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years",
          "maximumAge": "9 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02622321",
          "briefTitle": "A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-11-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hemophilia A"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 113,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04535414",
          "briefTitle": "Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Gastric Cancer", "Gastric Neoplasms", "Gastric Adenocarcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 195,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01945593",
          "briefTitle": "BAX 855 Continuation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-10-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-03-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hemophilia A"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 218,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04575961",
          "briefTitle": "Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-03-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Ovarian Cancer", "Low Grade Serous Carcinoma", "Primary Peritoneal Carcinoma", "Fallopian Tube Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04147195",
          "briefTitle": "Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Non-alcoholic Fatty Liver Disease", "Nonalcoholic Steatohepatitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06970275",
          "briefTitle": "To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-01-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Cancers", "Breast Cancer", "Head and Neck Cancer", "Cancer"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 850,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05078671",
          "briefTitle": "Pharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectiveness"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 160,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00306592",
          "briefTitle": "Natalizumab Re-Initiation of Dosing"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-03"
          },
          "completionDateStruct": {
            "date": "2008-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Sclerosis, Relapsing-Remitting"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 404,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00081328",
          "briefTitle": "Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-05"
          },
          "completionDateStruct": {
            "date": "2014-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus, Type II"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 699,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "10 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04808154",
          "briefTitle": "A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of SNP-630 in Health Subjects."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "NASH - Nonalcoholic Steatohepatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "20 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04444895",
          "briefTitle": "A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Angioedema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 73,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01251367",
          "briefTitle": "Dysport® Adult Lower Limb Spasticity Follow-on Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-06"
          },
          "completionDateStruct": {
            "date": "2015-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Post-stroke Spasticity", "Spasticity Post-Traumatic Brain Injury"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 352,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00112294",
          "briefTitle": "Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-12"
          },
          "completionDateStruct": {
            "date": "2008-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Small-Cell Lung Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 755,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01546753",
          "briefTitle": "Walnut Oral Immunotherapy for Tree Nut Allergy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-04-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Tree Nut Allergy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07028853",
          "briefTitle": "This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2034-12-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Castration Sensitive Prostate Cancer (mCSPC)", "Hormone Sensitive Prostate Cancer", "Prostate Cancer", "Cancer of the Prostate"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01621802",
          "briefTitle": "Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-06-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-11-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Measles-Mumps-Rubella"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4011,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "4 Years",
          "maximumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03014674",
          "briefTitle": "A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-08-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 246,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00107718",
          "briefTitle": "Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-11-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2006-05-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 64,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03630497",
          "briefTitle": "BN201 SAD MAD Study in Healthy Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Optic Neuritis", "Optic; Neuritis, With Demyelination"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07087561",
          "briefTitle": "Short-Term Nutritional Enhancement Combined With Health Education in Postoperative Colorectal Cancer Patients: A Randomized Controlled Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-10-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Colorectal Cancer (Diagnosis)", "Malnutrition or Risk of Malnutrition"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 360,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03346070",
          "briefTitle": "Efficacy and Safety of Sugammadex Dosed According to Actual Body Weight (ABW) or Ideal Body Weight (IBW) in Reversal of Neuromuscular Blockade (NMB) in Morbidly Obese Participants (MK-8616-146)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-01-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neuromuscular Blockade"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 207,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06462105",
          "briefTitle": "Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-05",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06905834",
          "briefTitle": "Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Dry Eye Disease (DED)", "Graft-Versus-Host Disease(GVHD)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03365648",
          "briefTitle": "Efficacy and Safety of Lertal® as an add-on to Standard Therapy for Allergic Rhinoconjunctivitis in Pediatrics"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-09-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-11-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Allergic Rhinoconjunctivitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00162084",
          "briefTitle": "A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-04"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Heart Disease", "Ischemic Heart Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2000
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04681729",
          "briefTitle": "Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cold Urticaria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00560794",
          "briefTitle": "Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-01"
          },
          "completionDateStruct": {
            "date": "2014-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Lymphoblastic Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05983198",
          "briefTitle": "Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-11-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 29,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04212793",
          "briefTitle": "Detection of PitNET Tissue During TSS Using Bevacizumab-800CW"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pituitary Tumor", "Pituitary Adenoma", "Pituitary Macroadenoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00265148",
          "briefTitle": "Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-05-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2008-07-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Alzheimer's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00186121",
          "briefTitle": "Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2000-10"
          },
          "completionDateStruct": {
            "date": "2013-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01959698",
          "briefTitle": "Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-04-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["CD20 Positive", "Recurrent Diffuse Large B-Cell Lymphoma", "Refractory Diffuse Large B-Cell Lymphoma", "Stage I Diffuse Large B-Cell Lymphoma", "Stage II Diffuse Large B-Cell Lymphoma", "Stage III Diffuse Large B-Cell Lymphoma", "Stage IV Diffuse Large B-Cell Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 29,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03089060",
          "briefTitle": "Silicone Finger Cap (\"Silikonfingerling\")"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-09-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-02-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Finger Injuries"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06995274",
          "briefTitle": "Umbilical Cord Blood Therapy in a Child With Eosinophilic Duodenitis and Autism Spectrum Disorder: a Case Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Autism Spectrum Disorder", "Eosinophilic Gastrointestinal Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "4 Years",
          "maximumAge": "4 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03922308",
          "briefTitle": "Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acquired Thrombotic Thrombocytopenic Purpura (aTTP)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07118059",
          "briefTitle": "Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Tuberculosis", "Inflammation Biomarkers", "Liver Function Tests", "Iron Status", "Metabolomics", "Nutritional Status", "Clinical Outcomes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04176250",
          "briefTitle": "Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Tuberculosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 93,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02424513",
          "briefTitle": "A Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03"
          },
          "completionDateStruct": {
            "date": "2016-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03587116",
          "briefTitle": "A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-07-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hemophilia B", "Hemophilia A"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 212,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02962648",
          "briefTitle": "An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-06-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Iron Deficiency Anemia", "Iron Deficiency Anaemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 103,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01705977",
          "briefTitle": "Belimumab Assessment of Safety in SLE"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-11-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4019,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02049593",
          "briefTitle": "PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-06-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-10-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Cancer", "Unspecified Adult Solid Tumor"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05841758",
          "briefTitle": "Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-07-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Sarcoidosis, Pulmonary"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 140,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03233529",
          "briefTitle": "Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Dermatitis, Atopic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02033109",
          "briefTitle": "Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-05"
          },
          "completionDateStruct": {
            "date": "2015-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "19 Years",
          "maximumAge": "49 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00766090",
          "briefTitle": "Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-10"
          },
          "completionDateStruct": {
            "date": "2009-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 190,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01218009",
          "briefTitle": "A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-10"
          },
          "completionDateStruct": {
            "date": "2010-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 331,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06451718",
          "briefTitle": "First in Human Study to Assess the Safety and the Efficacy of an Implantable Nitinol Device in the Treatment of Keratoconus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Keratoconus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06609239",
          "briefTitle": "Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-01-20",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 900,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05265273",
          "briefTitle": "A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-26",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Myasthenia Gravis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04744402",
          "briefTitle": "Phase 2 Clinical Trial of CartiLife® in the United States"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Articular Cartilage Defect", "Articular Cartilage Degeneration"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02347176",
          "briefTitle": "Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-02-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 204,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01767376",
          "briefTitle": "Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2014-01-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infections, Meningococcal"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 692,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "11 Years",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03068468",
          "briefTitle": "Study of BIIB092 in Participants With Progressive Supranuclear Palsy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-02-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Supranuclear Palsy, Progressive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 490,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "41 Years",
          "maximumAge": "86 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02141074",
          "briefTitle": "Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Congenital Bleeding Disorder", "Haemophilia B"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "0 Years",
          "maximumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03710408",
          "briefTitle": "Subcutaneous vs Intravenous Hydration on Older Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-11-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Dehydration"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 51,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04514731",
          "briefTitle": "Magnesium Sulfate and Neuroendocrine Hormone"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Arthropathy of Knee", "Magnesium Sulfate", "Cortisol", "Dehydroepiandrosterone"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "30 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05425927",
          "briefTitle": "Comparative Study of Conventional MR Images With Synthetically Reconstructed MR Images of the Brain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Clinical Indication for Brain MRI", "Healthy Volunteers"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 189,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02820844",
          "briefTitle": "Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-08-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-11-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Urinary Bladder, Overactive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 250,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03424629",
          "briefTitle": "Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2019-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Moderate and Severe Plaque Psoriasis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 57,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04155645",
          "briefTitle": "To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With Dyslipidemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Dyslipidemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06054633",
          "briefTitle": "L-arginine for Knee Osteoarthritis Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Osteoarthritis, Knee"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 340,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02840721",
          "briefTitle": "Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-08-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Colitis, Ulcerative"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00554606",
          "briefTitle": "Long-term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-10-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2009-08-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 115,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00095667",
          "briefTitle": "Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-11"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Recurrent Prostate Cancer", "Stage IV Prostate Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01119846",
          "briefTitle": "A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-06-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2010-03-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus, Type 2"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00549744",
          "briefTitle": "Clinical Endpoint Trial Investigating Once Daily and Bronchodilator Dosing"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-11-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2008-08-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 78,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03972709",
          "briefTitle": "A Study Assessing the Safety, Tolerability, and Efficacy of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Macular Degeneration, Age-Related", "Geographic Atrophy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 372,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05820152",
          "briefTitle": "Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leber Hereditary Optic Neuropathy (LHON)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05382494",
          "briefTitle": "Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-07-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Sleep Disorder; Breathing-Related", "Snoring", "Obstructive Sleep Apnea of Child", "Sleep Disorders in Children", "Tonsillar Hypertrophy", "Adenoidal Disorder"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 130,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06915727",
          "briefTitle": "An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-05-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Childhood Malignant Solid Neoplasm", "Childhood Malignant Thoracic Neoplasm", "Malignant Abdominal Neoplasm", "Malignant Neck Neoplasm", "Malignant Pelvic Neoplasm", "Metastatic Childhood Malignant Solid Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03274986",
          "briefTitle": "A Clinical Study of the ACRYSOF® IQ Extended Depth of Focus Intraocular Lens (IOL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-10-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cataract"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 242,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "22 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05791565",
          "briefTitle": "Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06805513",
          "briefTitle": "Actual Use Trial of Tadalafil 5 mg"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-02-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Erectile Dysfunction"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2250,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07054359",
          "briefTitle": "\"HBV unIversal vs Point-Of-Care-based Antiviral treatMent to Prevent Mother-to-child Transmission\""
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["HBV Infection", "Pregnancy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00541970",
          "briefTitle": "Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-10-17"
          },
          "completionDateStruct": {
            "date": "2013-03-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infections, Papillomavirus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 961,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "9 Years",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02849418",
          "briefTitle": "Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Urinary Bladder, Overactive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03931083",
          "briefTitle": "Screening Test Accuracy of Gynocular™, HR-HPV Testing, VIA for Detection of Cervical Neoplastic Lesions, in Women Living With HIV"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Uterine Cervical Neoplasms", "HIV/AIDS"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 450,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05263908",
          "briefTitle": "A Study to Learn About PAXLOVID (a Commercial Medicine) In People With COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "SARS-CoV-2 Infection"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 3346,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00122681",
          "briefTitle": "Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-05-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2009-11-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infections, Papillomavirus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18729,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "15 Years",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05377229",
          "briefTitle": "MarginProbe 2.0 Data Collection Protocol"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Cancer"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 398,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02871635",
          "briefTitle": "BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-09-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-05-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 147,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02879097",
          "briefTitle": "Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12"
          },
          "completionDateStruct": {
            "date": "2018-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Small Cell Lung Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02207673",
          "briefTitle": "A New Method for Delineation of Epileptic Brian Tissue During Epilepsy Surgery (The HFO Study)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11"
          },
          "completionDateStruct": {
            "date": "2021-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Refractory Localization-related Epilepsy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 78,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07160205",
          "briefTitle": "Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Idiopathic Inflammatory Myositis (IIM)", "DERMATOMYOSITIS OR POLYMYOSITIS"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02354586",
          "briefTitle": "A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ovarian Neoplasms", "Ovarian Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 463,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00289783",
          "briefTitle": "Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-02-22"
          },
          "completionDateStruct": {
            "date": "2008-02-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Haemophilus Influenzae Type b", "Neisseria Meningitidis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4441,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "6 Weeks",
          "maximumAge": "15 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03192969",
          "briefTitle": "A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-11-23",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Giant Cell Arteritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03997786",
          "briefTitle": "A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-12-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Moderate-to-severe Chronic Plaque Psoriasis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 130,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "215 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01149343",
          "briefTitle": "Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-07-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-12-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 107,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00363480",
          "briefTitle": "Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-05-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2007-09-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 221,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03733353",
          "briefTitle": "A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Psoriasis", "Atopic Dermatitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 204,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      }
    ],
    "protocolSection.1": [
      {
        "identificationModule": {
          "nctId": "NCT05062213",
          "briefTitle": "A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion in Adults of Atopic Dermatitis."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-05-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03030417",
          "briefTitle": "Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Solid Tumors", "Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02093923",
          "briefTitle": "A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-05-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-05-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hereditary Angioedema (HAE)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00753415",
          "briefTitle": "A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-08"
          },
          "completionDateStruct": {
            "date": "2011-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Non-Small Cell Lung Carcinoma", "Breast Cancer", "Melanoma", "Upper GI Tract Carcinoma", "Colon Carcinoma", "Renal Cell Carcinoma", "Bladder Carcinoma", "Prostate Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 37,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00451035",
          "briefTitle": "Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-02-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2008-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Myeloid Leukemia in Chronic Phase"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 29,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05058391",
          "briefTitle": "A Study of Elaprase in Children and Adults With Hunter Syndrome (Mucopolysaccharidosis II) in India"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-04-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hunter Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05275010",
          "briefTitle": "A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combination of Pertuzumab and Trastuzumab Administered Subcutaneously Using a Handheld Syringe or Using the On-Body Delivery System"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy Male Subjects"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 151,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07264114",
          "briefTitle": "Aquatic High-Intensity Interval Training for Parkinson's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-04-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Parkinson Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07021989",
          "briefTitle": "ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-31",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2033-04-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hodgkin Lymphoma, Adult", "Refractory Hodgkin Lymphoma", "Classic Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02938221",
          "briefTitle": "Telemedical Examination of a Three-Component Oculomotor Testing Battery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10"
          },
          "completionDateStruct": {
            "date": "2016-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Stroke", "Vertigo", "Dizziness"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01662063",
          "briefTitle": "A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-08"
          },
          "completionDateStruct": {
            "date": "2014-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 218,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02694978",
          "briefTitle": "A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-02-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-07-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Iron Deficiency Anemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2014,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02638948",
          "briefTitle": "Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-02-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 508,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05222269",
          "briefTitle": "[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-01-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "CNS Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07272642",
          "briefTitle": "A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Imaging", "Colorectal Cancer", "Head and Neck Squamous Cell Carcinoma", "Non-Small Cell Lung Cancer", "Triple Negative Breast Cancer (TNBC)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02689349",
          "briefTitle": "Esteem New Subject Enrollment Post Approval Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Sensorineural Hearing Loss"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 117,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01127893",
          "briefTitle": "Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-06-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2010-09-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Osteoarthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02424799",
          "briefTitle": "Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-11-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Urticaria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02271334",
          "briefTitle": "Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-08"
          },
          "completionDateStruct": {
            "date": "2015-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00817063",
          "briefTitle": "Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-01-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2012-04-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Eczema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 599,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02499146",
          "briefTitle": "Palbociclib Pharmacokinetics Study In Postmenopausal Chinese Women With ER (+), HER2 (-) Advanced Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 26,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04329650",
          "briefTitle": "Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-02-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 163,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00195650",
          "briefTitle": "Long Term Open Label Continuation Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2000-07"
          },
          "completionDateStruct": {
            "date": "2011-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 846,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06960382",
          "briefTitle": "Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08-26",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Allergic Rhinitis", "Allergic Asthma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01086410",
          "briefTitle": "Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-03"
          },
          "completionDateStruct": {
            "date": "2010-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 185,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03856047",
          "briefTitle": "Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-03-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Overweight", "Obesity"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 706,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04878055",
          "briefTitle": "Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pneumonia, Viral"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 287,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05968768",
          "briefTitle": "To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ewing Sarcoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00449761",
          "briefTitle": "Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-02-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2008-08-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia, Myeloid, Chronic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 27,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02991859",
          "briefTitle": "Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03292588",
          "briefTitle": "A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-11-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-04-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 335,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03704467",
          "briefTitle": "Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-11-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ovarian Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02178592",
          "briefTitle": "Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-03-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Infection, Human Immunodeficiency Virus", "HIV Infections"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 113,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00725712",
          "briefTitle": "Study of GSK1363089 in Metastatic Gastric Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-03-31"
          },
          "completionDateStruct": {
            "date": "2009-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms, Gastrointestinal Tract"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 74,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02573233",
          "briefTitle": "Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-01-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04333147",
          "briefTitle": "Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Arthritis, Rheumatoid"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2916,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04311515",
          "briefTitle": "To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-11-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Alzheimer Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03541187",
          "briefTitle": "Cockroach Immunotherapy in Children and Adolescents"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-07-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Persistent Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "8 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03538626",
          "briefTitle": "Phase I, Open-Label, Dose-Escalation Study of a Human Monoclonal Antibody, VRC-HIVMAB091-00-AB (N6LS), Administered Intravenously or Subcutaneously With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Antibodies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06189638",
          "briefTitle": "Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Foot Ulcers"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05035108",
          "briefTitle": "The Treatment of Bioartificial Liver With hiHep Cells After Extensive Hepatectomy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatoma Resectable"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03594955",
          "briefTitle": "First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-02-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukaemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02229227",
          "briefTitle": "Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-07-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus, Type 2"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 814,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06871969",
          "briefTitle": "Clinical Evaluation of EEG Device for the Triage of Stroke Patients in the Ambulance"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Ischemic Stroke", "Stroke", "Cardiovascular Diseases", "Vascular Diseases", "Central Nervous System Diseases", "Brain Diseases", "Nervous System Diseases", "Cerebrovascular Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 275,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03253744",
          "briefTitle": "Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-07-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Cancer", "Prostatic Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03755934",
          "briefTitle": "Efficacy and Safety of MEDI7352 in Participants With Painful Diabetic Neuropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-06-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Painful Diabetic Neuropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02750930",
          "briefTitle": "Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-03-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus, Type 2"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05392192",
          "briefTitle": "A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-04-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Cough"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 51,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02293499",
          "briefTitle": "Peer Led Asthma Self Management for Adolescents: PLASMA"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-05-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 371,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06688201",
          "briefTitle": "Minimally Invasive Soft Channel Brain Haemorrhage Evacuation for Acute Basal Ganglia Haemorrhage-- Large Hemorrhage Evacuation (MIRACLE-L)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Intracerebral Hemorrhage"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 550,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05210101",
          "briefTitle": "A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "SARS CoV 2 Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 93,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03414151",
          "briefTitle": "Gut Microbiome in AP Naive"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Psychotic Disorder", "Schizophrenia"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "35 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02924688",
          "briefTitle": "A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2436,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01441882",
          "briefTitle": "Dasatinib in Treating Patients With Chronic Lymphocytic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-10"
          },
          "completionDateStruct": {
            "date": "2018-01-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Refractory Chronic Lymphocytic Leukemia", "Stage I Chronic Lymphocytic Leukemia", "Stage II Chronic Lymphocytic Leukemia", "Stage III Chronic Lymphocytic Leukemia", "Stage IV Chronic Lymphocytic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 19,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06365359",
          "briefTitle": "Systemic Lupus Erythematosus and Chlordecone Impregnation in Martinique"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Systemic Lupus Erythematosus", "Renal Disease"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02557295",
          "briefTitle": "An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-12-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-03-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 248,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04426695",
          "briefTitle": "Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2252,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04089566",
          "briefTitle": "Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Muscular Atrophy, Spinal"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 145,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "7 Days"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02858037",
          "briefTitle": "Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-10-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Human Immunodeficiency Virus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1456,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03560466",
          "briefTitle": "Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-04-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 378,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "11 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00863772",
          "briefTitle": "Tanezumab and Nerve Function In Arthritis Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-05-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2010-11-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Osteoarthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 220,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05579977",
          "briefTitle": "Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes Mellitus", "Obesity"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 902,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04180163",
          "briefTitle": "Efficacy and Safety of Lanadelumab (SHP643) in Japanese Participants With Hereditary Angioedema (HAE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hereditary Angioedema (HAE)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05096221",
          "briefTitle": "A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Duchenne Muscular Dystrophy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 126,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "4 Years",
          "maximumAge": "7 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04983095",
          "briefTitle": "Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2033-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Cancer Metastatic", "Radiation Therapy", "Positron-Emission Tomography"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 118,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02169882",
          "briefTitle": "High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-05-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Tuberculosis, Meningeal"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01299610",
          "briefTitle": "A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-12-01"
          },
          "completionDateStruct": {
            "date": "2011-04-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Dermatitis, Atopic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05011916",
          "briefTitle": "The Safety and Efficacy of KDR2-2 Suspension Eye Drops in the Treatment of Corneal Neovascularization"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Corneal Neovascularization"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03038087",
          "briefTitle": "A Study to Test the SENSE Device in Patients With Intracranial Hemorrhage"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Intracerebral Hemorrhage", "Stroke, Acute", "Stroke Hemorrhagic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "22 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04366349",
          "briefTitle": "A Study to Evaluate the Safety and Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Melrilimab (GSK3772847) in Healthy Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Healthy Volunteers", "Asthma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 65,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03384693",
          "briefTitle": "Defibrotide TMA Prophylaxis Pilot Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Thrombotic Microangiopathies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01479621",
          "briefTitle": "A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-01"
          },
          "completionDateStruct": {
            "date": "2013-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 909,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05983328",
          "briefTitle": "Phase I Pharmacokinetic Study of HUYPS-1 in Healthy Volunteers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-02-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Nonalcoholic Steatohepatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "20 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01762852",
          "briefTitle": "Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-04"
          },
          "completionDateStruct": {
            "date": "2014-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Glomerulonephritis, Membranous"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01566695",
          "briefTitle": "The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-04-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Myelodysplastic Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 216,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00950599",
          "briefTitle": "Study of Multiple Doses of Saxagliptin (BMS-477118)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-05"
          },
          "completionDateStruct": {
            "date": "2004-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Type 2 Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 423,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02429791",
          "briefTitle": "Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-04-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 510,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04950374",
          "briefTitle": "A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion and a Lip Moisturizer in Adults of Atopic Dermatitis."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-26",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-12-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "59 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04680962",
          "briefTitle": "MabionCD20® Compared to MabThera® and Rituxan® in Patients With Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04489940",
          "briefTitle": "Bintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Triple Negative Breast Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04230213",
          "briefTitle": "A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 455,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01494610",
          "briefTitle": "Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-10-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2011-06-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05749874",
          "briefTitle": "Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["PreDiabetes", "Abdominal Obesity", "Hypertension", "Dyslipidemias", "Atherosclerotic Cardiovascular Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2024,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04330118",
          "briefTitle": "Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Drug Hypersensitivity", "DRESS Syndrome"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01648582",
          "briefTitle": "A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-07"
          },
          "completionDateStruct": {
            "date": "2014-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Type 2 Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 774,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01207388",
          "briefTitle": "Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11"
          },
          "completionDateStruct": {
            "date": "2019-01-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "B-cell Acute Lymphoblastic Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 116,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03012061",
          "briefTitle": "Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 425,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02002702",
          "briefTitle": "Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01"
          },
          "completionDateStruct": {
            "date": "2014-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Heart Failure"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04370054",
          "briefTitle": "Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-10-25",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hemophilia A"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 77,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05610488",
          "briefTitle": "Intravitreal Faricimab in Diabetic Macular Edema With Limited Response to Aflibercept"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Macular Edema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06945705",
          "briefTitle": "A Clinical Trial of Furmonertinib Combined With Anlotinib as First-line Treatment for Advanced NSCLC With EGFR-sensitive Mutations and Brain Metastasis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-10-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "NSCLC"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 146,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04025879",
          "briefTitle": "A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-07-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Non-Small-Cell Lung"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 461,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02940886",
          "briefTitle": "Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-03-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Iron Deficiency Anaemia", "Iron Deficiency Anemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1512,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02325674",
          "briefTitle": "MEASuRE: Metreleptin Effectiveness And Safety Registry"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Generalised Lipodystrophy", "Partial Lipodystrophy"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06085079",
          "briefTitle": "Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Uveitis, Posterior", "Uveitis, Anterior", "Uveitis, Intermediate", "Panuveitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04359095",
          "briefTitle": "Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 650,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01059786",
          "briefTitle": "Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hairy Cell Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 69,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04179032",
          "briefTitle": "Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04-26",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02509026",
          "briefTitle": "Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-09-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Spondylitis, Ankylosing"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 210,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "49 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04217278",
          "briefTitle": "A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukaemia", "High-risk Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 333,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      }
    ],
    "protocolSection.2": [
      {
        "identificationModule": {
          "nctId": "NCT00659425",
          "briefTitle": "CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-09"
          },
          "completionDateStruct": {
            "date": "2014-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Non-Hodgkin's Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 57,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04546789",
          "briefTitle": "Effect of Hepatic Impairment on M2951 (BTK Inhibitor) PK"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatic Impairment"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "79 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00999518",
          "briefTitle": "A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-01-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2011-01-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystitis, Interstitial"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 205,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04484935",
          "briefTitle": "Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "RSV Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "0 Years",
          "maximumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05241535",
          "briefTitle": "Study to Evaluate the Effect of a Single Oral Dose of MT-7117 on the QT/QTc Interval in Healthy Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy Subjects"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 29,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02955355",
          "briefTitle": "Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Inflammatory Demyelinating Polyradiculoneuropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 85,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02154867",
          "briefTitle": "Fecal Microbial Transplantation in Treatment of Irritable Bowel Syndrome; a Double Blinded Placebo Controlled Trial."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12"
          },
          "completionDateStruct": {
            "date": "2016-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Irritable Bowel Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01308021",
          "briefTitle": "Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-12"
          },
          "completionDateStruct": {
            "date": "2011-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Grass Pollen Allergy", "Hay Fever"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 202,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03073785",
          "briefTitle": "Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-09-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Pancreatic Adenocarcinoma", "Recurrent Pancreatic Carcinoma", "Stage I Pancreatic Cancer AJCC v6 and v7", "Stage IA Pancreatic Cancer AJCC v6 and v7", "Stage IB Pancreatic Cancer AJCC v6 and v7", "Stage II Pancreatic Cancer AJCC v6 and v7", "Stage IIA Pancreatic Cancer AJCC v6 and v7", "Stage IIB Pancreatic Cancer AJCC v6 and v7", "Stage III Pancreatic Cancer AJCC v6 and v7", "Stage IV Pancreatic Cancer AJCC v6 and v7"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02135848",
          "briefTitle": "3 Month PHI PAD PoM Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-10-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2011-11-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Vascular Disease, Peripheral"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04851015",
          "briefTitle": "Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Pneumocystis", "Pneumocystis Pneumonia", "Pneumocystis Jirovecii Infection", "Pneumocystis Infections", "Pneumocystis Carinii Infection", "Pneumocystosis; Pneumonia (Etiology)", "Pneumocystis Carinii; Infection, Resulting From HIV Disease", "Pneumocystosis Associated With AIDS"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05448651",
          "briefTitle": "Safety and Biologic Impact (Pharmacodynamics) of Repeated Injections and Increasing Amounts of UPB-101 in Asthmatics"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03028467",
          "briefTitle": "Evaluation of Pharmacokinetics and Safety of GSK3196165 in Combination With Methotrexate in Japanese Subjects With Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-12-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Arthritis, Rheumatoid"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04428619",
          "briefTitle": "Percutaneous Electrical Nerve Field Stimulation for Adults With Irritable Bowel Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Irritable Bowel Syndrome", "Abdominal Pain", "Autonomic Nervous System Imbalance"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06790407",
          "briefTitle": "Observational Metabolic Health Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 96,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04848558",
          "briefTitle": "A Study of Nipocalimab in Healthy Male and Female Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-05-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 89,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06907485",
          "briefTitle": "A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Pediatric Brain Tumor"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04315948",
          "briefTitle": "Trial of Treatments for COVID-19 in Hospitalized Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Corona Virus Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1552,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05293626",
          "briefTitle": "Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Leber Hereditary Optic Neuropathy (LHON)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03510858",
          "briefTitle": "Randomized Controlled Trial on Colorectal Cancer Screening Among Quality Circles of Primary Care Physicians"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Colorectal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05859412",
          "briefTitle": "Mechanisms of Neurodynamic Treatments"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Carpal Tunnel Syndrome", "Neurodynamic Treatment", "Nerve Mobilisation", "Diffusion MRI", "Physiotherapy", "Mechanistic Trial"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 108,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03568136",
          "briefTitle": "Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-09-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Dermatitis, Atopic", "Eczema, Atopic", "Neurodermatitis, Atopic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06331728",
          "briefTitle": "Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IGNX001"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Peanut Allergy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00128492",
          "briefTitle": "Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-08"
          },
          "completionDateStruct": {
            "date": "2009-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 274,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01426334",
          "briefTitle": "Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-09"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Accelerated Phase Chronic Myelogenous Leukemia", "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Chronic Phase Chronic Myelogenous Leukemia", "Relapsing Chronic Myelogenous Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02110225",
          "briefTitle": "A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01037985",
          "briefTitle": "Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-12-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2010-09-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Scar Prevention"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05153148",
          "briefTitle": "A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-06-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Psoriatic Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 305,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00544674",
          "briefTitle": "PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-08"
          },
          "completionDateStruct": {
            "date": "2009-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01430585",
          "briefTitle": "Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-03"
          },
          "completionDateStruct": {
            "date": "2012-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Early Breast Cancer (Phase 2)", "Advanced Breast Cancer (Phase 1b)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00989417",
          "briefTitle": "Benefits of Implantable Cardioverter Defibrillator Follow-up Using Remote Monitoring"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-01"
          },
          "completionDateStruct": {
            "date": "2010-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Implantable Cardioverter-Defibrillators", "Ventricular Fibrillation", "Tachycardia, Ventricular"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 473,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03020160",
          "briefTitle": "A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks in Participants With Hemophilia A"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hemophilia A"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05252533",
          "briefTitle": "A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Juvenile Psoriatic Arthritis", "Psoriasis", "Arthritis, Juvenile"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04903093",
          "briefTitle": "A Study Evaluating Relative Bioavailability of an Oral Suspension of Abrocitinib and Effect of an Acid Reducing Agent on the Bioavailability of Abrocitinib and Assessing the Taste of Abrocitinib Oral Formulations."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy Volunteers"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 19,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07137104",
          "briefTitle": "Safety and Preliminary Effectiveness Study of Mesenchymal Stem Cells, HeXell-2020, in Patients With Stable Coronary Artery Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Coronary Artery Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01644500",
          "briefTitle": "A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-07"
          },
          "completionDateStruct": {
            "date": "2014-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Type 2 Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 737,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03845270",
          "briefTitle": "Her2-positive Lung Cancer Treated With Dedicated Drug"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Non Small Cell Lung Cancer Metastatic", "Non Small Cell Lung Cancer Stage III", "HER2 Gene Mutation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01221285",
          "briefTitle": "Development of Cockroach Immunotherapy by the Inner-City Asthma Consortium"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-09"
          },
          "completionDateStruct": {
            "date": "2011-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Asthma", "Perennial Allergic Rhinitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05476887",
          "briefTitle": "To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Paroxysmal Nocturnal Hemoglobinuria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04970212",
          "briefTitle": "Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Carcinoma, Hepatocellular", "Metastatic Liver Cancer"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 65,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04886999",
          "briefTitle": "Study in Adult Patients With Moderate to Severe Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 78,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05242471",
          "briefTitle": "A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-11-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 703,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02596763",
          "briefTitle": "Phone-based Safety Monitoring of Baclofen Prescriptions for Alcohol Use Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Alcohol Use Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 239,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06650748",
          "briefTitle": "Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant Endocrine Therapy Treatment With or Without CDK4/6 Inhibitors in HR+/HER2- Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Breast Cancer", "Early-stage Breast Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06637748",
          "briefTitle": "Echo and Electrocardiographic Findings in Children With Bronchial Asthma At Sohag University Hospital"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Bronchial Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05855967",
          "briefTitle": "A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Plaque Psoriasis", "Psoriatic Arthritis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 250,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05805007",
          "briefTitle": "Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis Pigmentosa"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Retinitis Pigmentosa"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05012865",
          "briefTitle": "Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Renal Cell Carcinoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05570994",
          "briefTitle": "177Lu-HTK03170 in mCRPC With PSMA Positive Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-05-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Castration-resistant Prostate Cancer", "Prostate Cancer Metastatic", "Castrate Resistant Prostate Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05509972",
          "briefTitle": "In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Knee Arthritis", "Knee Osteoarthritis", "Primary Osteoarthritis of Knee Nos", "Secondary Osteoarthritis of Knee Nos", "Rheumatoid Arthritis of Knee", "Instability, Joint", "Osteonecrosis", "Deformity Knee"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "45 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00775437",
          "briefTitle": "Active Juvenile Idiopathic Arthritis (JIA) Compassionate Use"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-03"
          },
          "completionDateStruct": {
            "date": "2013-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Juvenile Idiopathic Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "4 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06305598",
          "briefTitle": "Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Castration-Resistant Prostate Carcinoma", "Metastatic Prostate Carcinoma", "Stage IVB Prostate Cancer AJCC v8"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02619357",
          "briefTitle": "Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-03-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Disease, Chronic Obstructive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06521034",
          "briefTitle": "First-in-Human Phase I/II Study of FHND-9041 in Patients With EGFR Mutated Advanced Non-Small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Non-small Cell Lung Cancer", "EGFR Gene Mutation", "EGFR-TKI Sensitizing Mutation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 124,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07280065",
          "briefTitle": "REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-02",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "PTSD - Post Traumatic Stress Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1900,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03233230",
          "briefTitle": "Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-09-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-09-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 390,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03682965",
          "briefTitle": "Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-09-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-04-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Allergic Rhinitis Due to Tree Pollen", "Allergic Conjunctivitis", "Allergic Rhinoconjunctivitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02139644",
          "briefTitle": "Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-06"
          },
          "completionDateStruct": {
            "date": "2015-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 787,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03596684",
          "briefTitle": "Citrulline Efficacy to Improve Carbohydrate Metabolism Abnormalities in the Patient Treated With High Doses of Statin"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-02-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Atorvastatin"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01146652",
          "briefTitle": "Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-06-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2023,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03325738",
          "briefTitle": "Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-06-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-09-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Squamous Cell Cutaneous Carcinoma of the Skin"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04618016",
          "briefTitle": "Evaluation of Medium Cross-linked Polyethylene With and Without Vitamin E for Total Knee Arthroplasty"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2034-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Osteoarthritis, Knee", "Arthritis, Rheumatoid", "Intra-Articular Fractures", "Joint Instability", "Genu Valgum or Varum"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 605,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03211858",
          "briefTitle": "Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-01-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 597,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02433340",
          "briefTitle": "Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-04"
          },
          "completionDateStruct": {
            "date": "2016-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 158,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04753697",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Eosinophilic Esophagitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 430,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00900146",
          "briefTitle": "Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-04"
          },
          "completionDateStruct": {
            "date": "2010-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus, Type 2"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 556,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "74 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02163759",
          "briefTitle": "A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-03-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 358,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04598555",
          "briefTitle": "Study on Patterns of Care in Mild Asthmatic Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 981,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00635089",
          "briefTitle": "Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-07"
          },
          "completionDateStruct": {
            "date": "2012-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Eosinophilic Esophagitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 190,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02135419",
          "briefTitle": "Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-09-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Anal Cancer", "High-grade Squamous Intraepithelial Lesion", "HIV Infection", "Human Papilloma Virus Infection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4446,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "35 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01823705",
          "briefTitle": "Gastric Electrical Stimulation (GES) for the Treatment of Obesity"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-03-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-01-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Obesity"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04622592",
          "briefTitle": "Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-04-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 209,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04360187",
          "briefTitle": "Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-09-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 391,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01357889",
          "briefTitle": "Pharmacokinetics/Pharmacodynamics of Albiglutide"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-07"
          },
          "completionDateStruct": {
            "date": "2012-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus, Type 2"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 283,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07189091",
          "briefTitle": "CReep and Maintenance flUid Sodium Chloride ADministration rEduction in cRitically Ill adultS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-07-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Critical Care, Intensive Care", "Fluid Accumulation", "Fluid and Electrolyte Imbalance", "Critical Illness", "Fluid Balance Outcomes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 640,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05132543",
          "briefTitle": "Neural Basis of Cognition"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-09-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Epilepsy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03991013",
          "briefTitle": "Tenofovir-lamivudine-dolutegravir Combination as Second-line ART: a Randomised Controlled Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-08-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 192,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03542994",
          "briefTitle": "A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-01-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Psoriasis", "Atopic Dermatitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 114,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00910962",
          "briefTitle": "A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-10-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2012-03-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Coronary Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 526,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01659723",
          "briefTitle": "Radiation Induced Cystitis Treated With Hyperbaric Oxygen - A Randomized Controlled Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-08"
          },
          "completionDateStruct": {
            "date": "2018-08-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystitis, Radio Induced"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 75,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05075642",
          "briefTitle": "Multicenter Observational Study for the Evaluation in Clinical Practice of Urinary Disorders in Multiple Sclerosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Multiple Sclerosis", "Urinary Bladder, Neurogenic"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 214,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07215273",
          "briefTitle": "Study of EL219 vs Standard of Care for Early Antifungal Therapy of Suspected Invasive Mould Infections"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Suspected Invasive Mould Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03744910",
          "briefTitle": "Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Antibody-mediated Rejection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 194,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04453384",
          "briefTitle": "Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "SARS Virus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 416,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02118792",
          "briefTitle": "Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03"
          },
          "completionDateStruct": {
            "date": "2015-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Dermatitis, Atopic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 764,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01283971",
          "briefTitle": "A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-05"
          },
          "completionDateStruct": {
            "date": "2012-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 96,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04950504",
          "briefTitle": "Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Peanut Allergy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07203339",
          "briefTitle": "Home-based Transcranial Direct Current Stimulation (tDCS) Compared to Duloxetine:On-inferiority Clinical Trial (FIBROSTIM)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Fibromyalgia (FM)", "tDCS", "Duloxetine", "BDNF", "EEG"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 610,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02171429",
          "briefTitle": "A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 358,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05328531",
          "briefTitle": "Clinical Study of Genakumab for Injection in Patients With Acute Gout"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Gout"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 121,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00783302",
          "briefTitle": "Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical Care"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-09"
          },
          "completionDateStruct": {
            "date": "2011-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Coronary Artery Disease (CAD)"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 885,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00924170",
          "briefTitle": "Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-10-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Adult T-Cell Leukemia (ATL)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06219083",
          "briefTitle": "Nutritional Status and Clinical Outcomes in Patients With Common Malignancies(NCOM)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cancer", "Chemoradiotherapy", "Nutrition, Healthy", "Oncology", "Clinical Outcomes"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1538,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00523341",
          "briefTitle": "Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-08-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-07-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Osteopenia", "Osteoporosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4550,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "60 Years",
          "maximumAge": "94 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04934072",
          "briefTitle": "A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Postmenopausal Osteoporosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 553,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "55 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06892093",
          "briefTitle": "Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["HER2-positive Breast Cancer", "Diarrhea Caused by Drug", "Neratinib"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 308,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02831764",
          "briefTitle": "An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Infection, Human Immunodeficiency Virus", "HIV Infections"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 722,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04976192",
          "briefTitle": "Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Urticaria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 608,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05609630",
          "briefTitle": "Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Juvenile Idiopathic Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03100500",
          "briefTitle": "A Long-term Safety Study of QMF149 in Japanese Participants With Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-04-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 51,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      }
    ]
  }
}
